Saint Louis Medical Weight Loss, LLC（St. Louis, MO）

Saint Louis Medical Weight Loss, LLC operates in St. Louis, Missouri, under the clinical direction of Anissa Wheeler, a Family Nurse Practitioner who focuses exclusively on medical weight management and hormone optimization. The clinic provides in-person consultations for patients seeking prescription weight loss interventions, with a treatment model centered on GLP-1 receptor agonist therapies. Wheeler’s practice emphasizes individualized dosing protocols and ongoing metabolic monitoring rather than one-size-fits-all approaches to weight reduction.

The clinic’s formulary includes Tirzepatide and Semaglutide, two FDA-approved medications that function by mimicking incretin hormones to regulate appetite and glucose metabolism. Tirzepatide acts on both GIP and GLP-1 receptors, while Semaglutide targets GLP-1 receptors specifically. Wheeler prescribes these peptides based on patient-specific factors including baseline metabolic markers, weight loss goals, comorbid conditions such as type 2 diabetes or metabolic syndrome, and tolerance profiles. The clinic structures treatment in titration phases, adjusting doses over weeks to minimize gastrointestinal side effects while optimizing therapeutic response. Patients receive guidance on nutrition modifications that complement peptide therapy, recognizing that medication efficacy improves when paired with dietary adjustments tailored to individual metabolic needs.

Anissa Wheeler brings family medicine training to her weight loss practice, allowing her to address the interconnected nature of obesity, hormonal imbalances, and metabolic health. Her approach includes baseline laboratory assessment of thyroid function, insulin resistance markers, and sex hormone levels, recognizing that untreated hormonal dysfunction can impede weight loss progress. For patients presenting with symptoms of hormone dysregulation—such as fatigue, mood changes, or stubborn weight retention despite caloric restriction—Wheeler incorporates hormone optimization strategies alongside peptide therapy. This dual focus distinguishes the practice from weight loss clinics that address body composition in isolation from endocrine health.

Patients at Saint Louis Medical Weight Loss attend in-person visits at the St. Louis location, where Wheeler conducts physical assessments, reviews laboratory results, and adjusts treatment protocols based on progress metrics including weight trends, body composition changes, and subjective response to therapy. The clinic does not offer telehealth services, requiring patients to be physically present for consultations and follow-up appointments. This in-person model allows for direct clinical evaluation and immediate intervention if patients experience adverse effects or require dosage modifications. Follow-up intervals are determined by treatment phase, with more frequent visits during initial titration and extended intervals once patients reach maintenance dosing.

With a 4.7-star rating based on three Google reviews, Saint Louis Medical Weight Loss maintains a small but positively reviewed patient base in the St. Louis area. The clinic serves patients throughout the greater St. Louis metropolitan region who are seeking medically supervised weight loss with prescription peptide therapies. Wheeler’s practice model prioritizes clinical oversight and individualized treatment adjustments over high-volume patient throughput, reflecting a personalized care philosophy that aligns with the complex nature of metabolic weight management and hormone-related health concerns.